Vaccine Safety Panels to Evaluate Suspected Anaphylaxis Cases Based on Pfizer’s Reports

MHLW's Joint Safety Panel Meeting on April 9 Suspected cases of anaphylaxis observed in people who received Pfizer’s COVID-19 vaccine Comirnaty will be assessed based not only on reports from medical institutions but also on those from the manufacturer, panels...read more